Please provide your email address to receive an email when new articles are posted on . Intravitreal steroids have been widely used in the treatment of various ocular pathologies including macular ...
Please provide your email address to receive an email when new articles are posted on . Ozurdex is a biodegradable dexamethasone implant placed into the vitreous cavity in cases that are predisposed ...
OZURDEX (dexamethasone) intravitreal implant by Allergan Allergan's Ozurdex (dexamethasone intravitreal implant) has been approved by the FDA for the treatment of macular edema following branch ...
OZURDEX (dexamethasone) intravitreal implant by Allergan The FDA has approved Ozurdex (dexamethasone intravitreal implant, from Allergan) for the treatment of non-infectious ocular inflammation, or ...
Cost regulators for the NHS in England and Wales are backing routine use of Allergan’s Ozurdex and AbbVie’s Humira to treat non-infectious posterior uveitis, a form of preventable vision loss. Cost ...
Sixty-four eyes were prospectively investigated. Group 1 (22 central retinal vein occlusion (CRVO) and 16 branch retinal vein occlusion (BRVO)) was treated with Ozurdex alone, and group 2 (14 CRVO and ...
LONDON, May 21 (Reuters) - Allergan's injectable eye treatment Ozurdex won the backing of Europe's drug regulators on Friday, paving the way for the drug to be marketed in Europe in the third quarter ...
The National Institute for Health and Care Excellence (NICE) has issued draft guidance recommending the dexamethasone intravitreal implant for the treatment of diabetic macular oedema (DMO). The ...
Allergan’s eye drug Ozurdex has been approved in the EU to treat a sight-threatening condition that affects people with diabetes. The European Commission granted marketing authorisation to Ozurdex, an ...
Biodegradable implant delivers extended-release corticosteroid dexamethasone via intravitreal injection. FDA cleared Allergan’s Ozurdex® 0.7 mg for noninfectious ocular inflammation, or uveitis, ...
June 19 -- THURSDAY, June 18 (HealthDay News) -- An injectable eye implant approved by the U.S. Food and Drug Administration Thursday is the first product sanctioned to treat the eye disorder macular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results